Literature DB >> 17275289

Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse.

Robert U Simpson1, Steven H Hershey, Karl A Nibbelink.   

Abstract

Our previous studies showed vitamin D deficiency results in increased cardiac contractility, hypertrophy and fibrosis and has profound effects on heart proteomics, structure and function in rat. In this study we found that the heart in vitamin D receptor knockout (VDR-KO) mice is hypertrophied. Six homozygous VDR knockout (-/-), six wild type (+/+) and six heterozygous (+/-) mice were fed a diet containing 2% Ca, 1.25% P and 20% lactose to maintain normal blood calcium and phosphate levels for 12 months. Tail-cuff blood pressure was performed on all mice. Blood pressure determinations showed no differences in systolic or mean blood pressure in WT (+/+), KO (-/-) or HETERO (+/-) mice at 3 and 6 months. However, decreased systolic BP in the KO mice relative to WT at 9 months of age was observed. ECG analysis showed no significant differences in the intact KO, HETERO or WT mice. The mice were killed at 12 months. Heart weight/body weight ratio was 41% (P<.003) greater in the KO mice versus WT and HETERO was 19% (P<.05) increased versus WT. Other VDR-KO tissues did not display hypertrophy. Cross sectional and longitudinal analysis of the heart myofibrils showed highly significant cellular hypertrophy in VDR-KO mice. Trichrome staining of heart tissue showed marked increase in fibrotic lesions in the KO mice. Analysis of plasma renin activity, angiotensin II (AII) and aldosterone levels showed elevated but not significantly different renin activity in KO versus WT and no significant differences in AII or aldosterone levels. Our data do not support the concept that the renin-angiotensin system or hypertension are the factors that elicit these changes. Data presented here reveal that ablation of the VDR signaling system results in profound changes in heart structure. We propose that calcitriol acts directly on the heart as a tranquilizer by blunting cardiomyocyte hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17275289      PMCID: PMC1868539          DOI: 10.1016/j.jsbmb.2006.12.098

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  5 in total

Review 1.  The involvement of the endocrine system in regulating cardiovascular function: emphasis on vitamin D3.

Authors:  R E Weishaar; R U Simpson
Journal:  Endocr Rev       Date:  1989-08       Impact factor: 19.871

2.  Involvement of vitamin D3 with cardiovascular function. III. Effects on physical and morphological properties.

Authors:  R E Weishaar; S N Kim; D E Saunders; R U Simpson
Journal:  Am J Physiol       Date:  1990-01

3.  High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure.

Authors:  Ilkka Pörsti; Meng Fan; Peeter Kööbi; Pasi Jolma; Jarkko Kalliovalkama; Tuija I Vehmas; Heikki Helin; Harry Holthöfer; Eero Mervaala; Tuulikki Nyman; Ilkka Tikkanen
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

4.  Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?

Authors:  Armin Zittermann; Stefanie Schulze Schleithoff; Gero Tenderich; Heiner K Berthold; Reiner Körfer; Peter Stehle
Journal:  J Am Coll Cardiol       Date:  2003-01-01       Impact factor: 24.094

5.  Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems.

Authors:  Wei Xiang; Juan Kong; Songcang Chen; Li-Ping Cao; Guilin Qiao; Wei Zheng; Wenhua Liu; Xinmin Li; David G Gardner; Yan Chun Li
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-14       Impact factor: 4.310

  5 in total
  75 in total

1.  Serum vitamin D level and prehypertension among subjects free of hypertension.

Authors:  Charumathi Sabanayagam; Anoop Shankar; Shanmugasundaram Somasundaram
Journal:  Kidney Blood Press Res       Date:  2011-09-21       Impact factor: 2.687

2.  Congestive heart failure: where homeostasis begets dyshomeostasis.

Authors:  German Kamalov; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

Review 3.  Should hypertensive patients take vitamin D?

Authors:  Gregoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

Review 4.  Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia.

Authors:  David M Charytan; Steven Fishbane; Jolanta Malyszko; Peter A McCullough; David Goldsmith
Journal:  Am J Kidney Dis       Date:  2015-02-26       Impact factor: 8.860

Review 5.  Vitamin D and the heart.

Authors:  David G Gardner; Songcang Chen; Denis J Glenn
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-11       Impact factor: 3.619

6.  Vitamin D and Cardiovascular Disease: Can Novel Measures of Vitamin D Status Improve Risk Prediction and Address the Vitamin D Racial Paradox?

Authors:  Samuel M Kim; Pamela L Lutsey; Erin D Michos
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-01-21

7.  Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine.

Authors:  Gaurav K Gupta; Tanupriya Agrawal; Michael G DelCore; Syed M Mohiuddin; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2012-04-17       Impact factor: 3.362

8.  Membrane localization, Caveolin-3 association and rapid actions of vitamin D receptor in cardiac myocytes.

Authors:  Guisheng Zhao; Robert U Simpson
Journal:  Steroids       Date:  2009-12-14       Impact factor: 2.668

9.  Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction.

Authors:  Soochan Bae; Sylvia S Singh; Hyeon Yu; Ji Yoo Lee; Byung Ryul Cho; Peter M Kang
Journal:  J Appl Physiol (1985)       Date:  2013-02-21

10.  Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat.

Authors:  R Przybylski; S McCune; B Hollis; R U Simpson
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-10-15       Impact factor: 4.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.